INSIGHTS ON DRUG DEVELOPMENT

• Calcium Carbonate Vs Titanium Dioxide: Why Particle Engineering Matter

  Discover how particle-engineered calcium carbonate offers a viable alternative to titanium dioxide in tablet coatings, achieving good opacity, process efficiency, and comparable tablet properties.

• A Better Immune Response To Vaccination: Using Lymphoid Follicle Organ-Chips

  Discover a first-of-its-kind human LF-Chip containing B, T, plasma and antigen-presenting cells to test functional immunization responses to vaccines and adjuvants in vitro.

• White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges

  Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

• Protecting Human Health With Organ-On-A-Chip Technology

  Explore compelling evidence that suggests Organ-on-a-Chip technology offers a far more reliable means of predicting drug toxicity than traditional animal models.

• Getting Genomic Medicines Ready For Prime Time

  2/5/2024

  Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.

• A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma

  7/31/2025

  Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.

• Technology To Overcome Absorption Hurdles And Solubility Limitations

  3/6/2024

  For poorly soluble drugs, overcoming absorption hurdles can hinder development. Explore a solution that empowers researchers to overcome solubility limitations and accelerate drug development.

• Are Non-Human Primates A Research Dead End?

  2/13/2024

  The time has come to move away from using non-human primates as test subjects in biomedical research and embrace more practical, reproducible, and cost-effective models.

• Overcoming Challenges To High-Concentration Formulation Development

  3/25/2025

  Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.